Latest filing published 02 Mar 2018 for Sonoma Pharmaceuticals, Inc..
No signal scores available.
This profile gathers the share dealings of Sharon Surrey Barbari across 2 companies, led by Sonoma Pharmaceuticals, Inc. and Cytokinetics Inc. Between 16 November 2009 and 1 March 2018, the trades on record add up to 19 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 2 March 2018: a share grant, in Sonoma Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations